arthritis.
(4) The blood clotting factors are expensive and must be
injected intravenously several times per week, but this
medicine can be administered in the patient's home, the
preferred method of treatment.
(5) In addition to blood clotting factors, patients
require expert, specialized medical care at a regional
hemophilia treatment program affiliated with a hospital.
(6) The purpose of this act is to establish a standard
of care so that patients with severe bleeding disorders can
receive necessary and appropriate medical care.
Section 3. Definitions.
The following words and phrases when used in this act shall
have the meanings given to them in this section unless the
context clearly indicates otherwise:
"340B program." An outpatient pharmacy licensed by the
Commonwealth to dispense blood clotting products that is
conditionally or fully designated as a covered entity under the
Veterans Health Care Act of 1992 (Public Law 102-585, 106 Stat.
4943), which enacted section 340B of the Public Health Service
Act (58 Stat. 682, 42 U.S.C. § 256b).
"Ancillary infusion equipment and supplies." The equipment
and supplies required to infuse a blood clotting product into a
human vein, including, but not limited to, syringes, needles,
sterile gauze and alcohol swabs, tourniquets, medical tape,
sharps or equivalent biohazard waste containers and cold
compression packs.
"Bleeding disorder." A medical condition characterized by a
severe deficiency or absence of one or more essential blood
clotting proteins in the human blood, often called factors,
20160HB2364PN3910 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30